FMP

FMP

Enter

AXLA - Axcella Health Inc.

Financial Summary of Axcella Health Inc.(AXLA), Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The com

photo-url-https://financialmodelingprep.com/image-stock/AXLA.png

Axcella Health Inc.

AXLA

NASDAQ

Inactive Equity

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

0.401 USD

-0.0391 (-9.75%)

About

ceo

Mr. Craig R. Jalbert CIRA

sector

Healthcare

industry

Biotechnology

website

https://www.axcellahealth.com

exchange

NASDAQ

Description

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Mas...

CIK

0001633070

ISIN

US05454B2043

CUSIP

05454B105

Address

840 Memorial Drive

Phone

857 320 2200

Country

US

Employee

11

IPO Date

May 9, 2019

Summary

CIK

0001633070

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

05454B105

ISIN

US05454B2043

Country

US

Price

0.4

Beta

0.57

Volume Avg.

54.52k

Market Cap

1.18M

Shares

-

52-Week

0.34-41.25

DCF

0.28

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.02

P/B

-

Website

https://www.axcellahealth.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest AXLA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep